Release Date: 24/02/10 15:24 Summary: Revised Acquisition Terms and Capital Raising Price Sensitive: Yes Download Document 81.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%